A 5-HT2C receptor agonist for the treatment of obesity?

被引：0
|
作者：
Van Baak, M
Lentjes, M
Mujakovic, S
Slaap, B
Saris, W
机构：
来源：
OBESITY RESEARCH | 2003年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A110 / A111
页数：2
相关论文
共 50 条
  • [41] Lorcaserin, a Selective 5-HT2C Receptor Agonist, Reduces Energy Intake and Appetite
    Martin, Corby Kyle
    Redman, Leanne M.
    Zhang, Jinkun
    Anderson, Christen M.
    Smith, Steven R.
    Ravussin, Eric
    OBESITY, 2010, 18 : S150 - S150
  • [42] Agonist diversity in 5-HT2C receptor-mediated weight control in rats
    Aska Hayashi
    Masanori Suzuki
    Masao Sasamata
    Keiji Miyata
    Psychopharmacology, 2005, 178 : 241 - 249
  • [43] A 5-HT2c receptor agonist indicated to treat certain overweight or obese adults
    不详
    FORMULARY, 2012, 47 (09) : 312 - 312
  • [44] Effect of a 5-HT2c receptor agonist on urethral closure mechanisms in female rats
    Ouchi, Mifuka
    Kitta, Takeya
    Kanno, Yukiko
    Higuchi, Madoka
    Togo, Mio
    Moriya, Kimihiko
    Shinohara, Nobuo
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (08) : 2382 - 2388
  • [45] Effect of a 5-HT2c receptor agonist on urethral closure mechanism in healthy women
    Klarskov, Niels
    Van Till, Oliver
    Sawyer, Will
    Cernus, Dirk
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (06) : 1700 - 1706
  • [46] Anti-obesity effects of CP-809101, a selective 5-HT2C agonist
    Patterson, T
    Tomlinson, E
    Gibbons, C
    She, L
    Swick, A
    Dasilva-Jardine, P
    Marala, R
    Brown, J
    Kong, J
    Chiang, P
    Aspnes, G
    Novomisle, W
    Harris, A
    Kalvass, J
    Maurer, T
    OBESITY RESEARCH, 2005, 13 : A23 - A23
  • [47] Imaging the 5-HT2C receptor with PET: Evaluation of 5-HT2C and 5-HT2A affinity of pimavanserin in the primate brain
    Ridler, Khanum
    Rizzo, Gaia
    Burstein, Ethan S.
    Forsberg Moren, Anton
    Stepanov, Vladimir
    Halldin, Christer
    Rabiner, Eugenii A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2025, 45 (02): : 352 - 364
  • [48] Evaluation of selective 5-HT2c phenylpiperazine agonists for the treatment of obesity.
    Tsai, JH
    Smith, BM
    Chen, R
    Prieto, E
    Park, D
    Smith, J
    Schultz, JA
    Gallardo, C
    Estrada, S
    Fang, S
    Gilson, C
    Thomsen, W
    Saldana, H
    Bjenning, C
    Creehan, K
    Gonzalez, L
    Whelan, K
    Webb, RR
    Beeley, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U113 - U113
  • [49] Chronic treatment with SSRIs desensitizes both 5-HT2A and 5-HT2C receptor function
    Yamauchi, Miki
    Miyara, Takako
    Matsushima, Tetsuya
    Tatebayashi, Tomoko
    Yokoyama, Fumikazu
    Onozawa, Kaname
    Yoshida, Akiko
    Imanishi, Taiichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 84 - 84
  • [50] Synthesis and biological evaluation of novel, selective 5-HT2C receptor agonists for obesity
    Lee, T
    Robichaud, AJ
    Chen, WT
    Lu, YM
    Dowdell, S
    Boyle, KE
    Mitchell, IS
    Fevig, JM
    Wexler, RR
    Miller, KJ
    Largent, BL
    Rohrbach, KW
    Devenny, JJ
    McElroy, JF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U158 - U159
12345